Early mortality of alcoholic hepatitis: a review of data from placebo-controlled clinical trials (Q33580392)

28 July 2017

1 reference

title

Early mortality of alcoholic hepatitis: a review of data from placebo-controlled clinical trials (English)

1 reference

28 July 2017

0 references

1 reference

1 reference

Chao-Hui Yu

1

1 reference

28 July 2017

Cheng-Fu Xu

2

1 reference

28 July 2017

Hua Ye

3

1 reference

28 July 2017

Lan Li

4

1 reference

28 July 2017

You-Ming Li

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

World Journal of Gastroenterology

28 July 2017

published in

1 reference

28 July 2017

volume

16

1 reference

28 July 2017

issue

19

1 reference

28 July 2017

page(s)

2435-2439

1 reference

A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Systematic review: glucocorticosteroids for alcoholic hepatitis--a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Corticosteroids for alcoholic hepatitis--what's next?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

The epidemiology of alcoholic liver disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Epidemiology of alcoholic liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Pathogenesis and management of alcoholic hepatitis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Pathogenesis, diagnosis, and treatment of alcoholic liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

A randomized trial of prednisolone in patients with severe alcoholic hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Corticosteroid therapy of alcoholic hepatitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

A randomized placebo controlled trial of vitamin E for alcoholic hepatitis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Alcohol as a risk factor for global burden of disease

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874151

Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis

31 October 2018

1 reference

12 December 2020

Alcoholism and alcoholic liver disease: focusing on epidemiological investigation in Asia

1 reference

12 December 2020

Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy

1 reference

12 December 2020

A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients

1 reference

12 December 2020

Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis

1 reference

12 December 2020

Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone

1 reference

12 December 2020

Effect of parenteral amino acid supplementation in alcoholic hepatitis

1 reference

12 December 2020

A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis

1 reference

12 December 2020

Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial

1 reference

12 December 2020

Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial

1 reference

12 December 2020

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V16.I19.2435

1 reference

28 July 2017

1 reference

28 July 2017

1 reference